Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.6% in the afternoon session after the major indices pulled back ...

The Business Research Company The Business Research Company's Immersive Simulator Global Market Set For Rapid Expansion; Projected To Reach ...

The Business Research Company's Lung Cancer Liquid Biopsy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...

Addenbrooke’s Charitable Trust is 30 years old - and to celebrate, we’ve been looking back at some of the many projects the ...

This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput ...

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving ...

Researchers have mapped human fat tissue at single-cell resolution, uncovering how obesity alters cellular stress, ...

Illumina's stock price edged 0.4% lower to $90.11. Illumina's acquisition of SomaLogic, which has approximately 250 employees, includes the company's lab, office and manufacturing facilities in ...

Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.

The saga between Illumina and Grail reaches its conclusion as divestment is enforced following legal proceedings with the European Commission and US Federal Trade Commission.